• Linkdin

iFabric to distribute ECT patient gowns in Canada

11 Jul '12
3 min read

iFabric Corp, announced that it has been granted the exclusive Canadian distribution rights for the USA patented Patient  Gown by ECT Solutions LLC “ECT”, Coral Springs, Florida. The ECT Patient Gown is currently pending patent approval in Canada.

The ECT Patient Gown is made of a cloth material with a secured back, large pockets and various slit openings. All of these openings are strategically placed allowing the bedside care provider to monitor the patient without having to expose them which allows the gown to fully and completely cover the patient.

The ECT Patient Gown is a thoughtfully designed gown that provides health care providers easy access while maintaining the dignity and privacy of the patient.

Designed by a nurse to help improve patient outcomes and increase nursing efficiency, the ECT Patient Gown allows drainage, feeding and central line tubes to pass through the gown so they are easily visible during bedside care, reducing the risk of misconnections. 

One size fits most patients and a generous overlap in the back eliminates the need to put two gowns on the patient in order to protect the patient’s modesty.  Built-in central line slits separate lumens from the skin helping to minimize the risk of infections. 

Drain line and PEG tube slits prevent stress on insertion sites minimizing the need for re-applying dressings.  Large pockets hold drains, pain pumps, etc., for easier patient ambulation.

A further benefit of this agreement is that ECT will be integrating iFabric’s CLINIWEAVE anti-microbial technology in its product line.

“After extensive review of available anti-microbials, ECT chose iFabric’s CLINIWEAVE anti-microbial technology for its class leading performance” stated Mrs. Chantale Trouillot, President of ECT Solutions LLC.

“The ECT Gown, impregnated with Cliniweave, is another vehicle that not only promotes our anti-microbial technology, but expands our product base for value added revenue,” added Mr. Hylton Karon, President and CEO of iFabric.

CLINIWEAVE is effective against a wide range of micro-organisms including mold, mildew, fungi and odor causing bacteria. It provides long-term, effective control of microorganisms. This efficacy and safety has been documented in numerous peer reviewed publications, trade articles and certified tests. It is durable to deterioration through repeated washing and is clinically proven to kill bacteria associated with hospital acquired infections.

Medical uses for Cliniweave include bedding, curtaining, air filters, scrubs, masks and surfaces amongst others.

iFABRIC CORP currently has 25.2 million shares issued and outstanding. iFABRIC is a manufacturer, distributor, licensor and licensee of  ladies intimate apparel products and accessories as well proprietary chemical compounds that render fabrics intelligent, thereby improving the safety and well-being of the wearer.

iFabric Corp

Leave your Comments

Esteemed Clients

TÜYAP IHTISAS FUARLARI A.S.
Tradewind International Servicing
Thermore (Far East) Ltd.
The LYCRA Company Singapore  Pte. Ltd
Thai Trade Center
Thai Acrylic Fibre Company Limited
TEXVALLEY MARKET LIMITED
TESTEX AG, Swiss Textile Testing Institute
Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)
Taiwan Textile Federation (TTF)
SUZHOU TUE HI-TECH NONWOVEN MACHINERY CO.,LTD
Stahl Holdings B.V.,
Advanced Search